Metraipolis › archive › dc_68c196ff89f2
Importance of Inhibitor Surveillance During Emicizumab Prophylaxis in Young Children With Hemophilia: An Illustrative Case Series — Europe PMC PMID:41255845
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41255845
- DOI
- 10.1155/crh/5572714
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:46:10.480Z
- SHA-256 of the archived text
41494ef6fc69c2b2b5cdadf7707d338c40ee09906122b7ab3ad6c3f145c75461- Stable URL of this page
https://metraipolis.com/documento/dc_68c196ff89f2
How to cite
Importance of Inhibitor Surveillance During Emicizumab Prophylaxis in Young Children With Hemophilia: An Illustrative Case Series — Europe PMC PMID:41255845 — Europe PMC (en), https://europepmc.org/article/MED/41255845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68c196ff89f2 (Metraipolis archive dc_68c196ff89f2, sha256 41494ef6fc69c2b2b5cdadf7707d338c40ee09906122b7ab3ad6c3f145c75461)
BibTeX
@misc{dc68c196ff89f2,
title = {Importance of Inhibitor Surveillance During Emicizumab Prophylaxis in Young Children With Hemophilia: An Illustrative Case Series — Europe PMC PMID:41255845},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41255845},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68c196ff89f2; sha256 41494ef6fc69c2b2b5cdadf7707d338c40ee09906122b7ab3ad6c3f145c75461},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41255845. Agents can read the archived copy with the MCP tool read_document.